Caroline Kovac joined Burrill & Company after retiring from IBM where she was responsible for the strategic direction of IBM’s global healthcare and life sciences business. She leads a team in developing the latest information technology solutions and services, establishing partnerships and overseeing IBM investment within the healthcare, pharmaceutical, and life sciences markets.
In 20 years at IBM, Caroline held a number of executive management positions, including vice president at IBM Research, where she was instrumental in launching the Computational Biology Center and the massive Blue Gene supercomputer project.
With only two employees in 2000, Caroline grew IBM’s life sciences business unit into a multi-billion dollar business and one of IBM’s most successful ventures to date with over 1500 employees worldwide.
Her main focus at Burrill is developing and executing investment strategies for leading-edge technologies that contribute to the transformation of medicine and healthcare including personalized medicine, the use of IT in healthcare, stem cell research, medical devices and diagnostics, and bio-nanotechnology.
In addition, she will work as part of the Burrill International Group team building the company’s life science focus on emerging economies like China, India, Malaysia, and the Middle East.